Following completion of this course, physicians will be able to:
- Understand the mechanisms of action (MOA) of RANKL inhibitors and parathyroid hormone (PTH) derivatives, and how their MOA relates to efficacy
- Select an appropriate therapy for each patient based on the benefits and risks
Please select a module below to view the topics covered. Pages must be marked as complete to progress through the course.